The remaining packages of Glucosamine Evalar have been withdrawn from circulation

0
1039

Evalar said it has withdrawn Glucosamine Evalar from circulation. The packages that were on the market had remained there after the cancellation of state registration. This is reported by Katren Style with reference to the information letter published on Roszdravnadzor website.

This concerns series 0048791219, 0058791219, 0018791220, 0028791220, 0038791220, 0018790421, 0028790421, and 0038790421 of Glucosamine Evalar, powder for oral solution, 1500 mg, sachets (20), in cardboard packs, produced by ZAO Evalar (Russia).

The state registration of this drug was canceled in early November based on the decision of the registration certificate holder.